✦ LIBER ✦

P-2-35 Efficacy of fluoxetine in comparison to maprotiline and amitriptyline in major depression with anxious features

✍ Scribed by D. Bugarski-Kirola; S. Totic; A. Damjanovic; Dj. Zivkovic

Book ID: 119176106
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 137 KB
Volume: 5
Category: Article
ISSN: 0924-977X
DOI: 10.1016/0924-977x(95)90400-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.1.139 Fluoxetine vs maprotiline in the

P.1.139 Fluoxetine vs maprotiline in the treatment of major depression in hospitalised patients: Comparison of efficacy and side effects

✍ M. Dossenbach; V. Riedl; V. De Verga; D. Milovanovic; E. Till; H. Klech 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 126 KB

P-2-88 Comparison of fluvoxamine and flu

P-2-88 Comparison of fluvoxamine and fluoxetine in major depression

✍ M. Rapaport; E. Coccaro; Y. Sheline; P. Holland; T. Perse; L. Fabre 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 140 KB

P-12-22 - Efficacy and tolerability of f

P-12-22 - Efficacy and tolerability of fluoxetine compared with maprotiline in major depressive episode: Results of central-east european study

✍ M. Jakovljeviç; D. Vujiç; Y. Aleksandrovsky; W. Szerenberger; F. Faltus; N. Heni 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 150 KB

O-19-7 - Comparison of efficacy and tole

O-19-7 - Comparison of efficacy and tolerability of fluoxetine in ambulatory and hospitalized patients with major depression

✍ I. Timotijević; V.R. Paunović; Z. Pavlović 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Comparison of efficacy and tolerability

Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study

✍ Cengiz Akkaya; Enver Yusuf Sivrioglu; Semra Akgoz; Salih Saygin Eker; Selcuk Kir 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

## Objective: The aim of this study was to compare the efficacy and tolerability of reboxetine in the treatment of major depressive disorder (mdd) and mdd with anxiety features to venlafaxine xr. ## Method: Patients with mdd, aging 18 between 65 years, were randomly allocated to two groups receiv

P.1.070 A randomized, double-blind compa

P.1.070 A randomized, double-blind comparison of mirtazapine and fluoxetine in patients with major depression

✍ D. Wheatley; C.M.E. Kremer 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 147 KB